[Cancer immunotherapy].
Vakkila
J
J
Biotekniikan Instituutti PL56, 00014 Helsingin yliopisto. jukka.vakkila@huch.fi
Pihkala
U
U
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000951:Antigens, Neoplasm / Q000276:immunology; D016207:Cytokines / Q000378:metabolism / Q000627:therapeutic use; D003713:Dendritic Cells / Q000276:immunology; D006801:Humans; D007167:Immunotherapy / Q000379:methods* / Q000639:trends; D007694:Killer Cells, Natural / Q000276:immunology; D009369:Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D014612:Vaccines / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D016207:Cytokines; D014612:Vaccines